390 related articles for article (PubMed ID: 17403708)
1. Reversal of resistance in microorganisms by help of non-antibiotics.
Kristiansen JE; Hendricks O; Delvin T; Butterworth TS; Aagaard L; Christensen JB; Flores VC; Keyzer H
J Antimicrob Chemother; 2007 Jun; 59(6):1271-9. PubMed ID: 17403708
[TBL] [Abstract][Full Text] [Related]
2. [Gram-positive bacterial infections resistant to antibiotic treatment].
Utili R
Ann Ital Med Int; 2001; 16(4):205-19. PubMed ID: 11799629
[TBL] [Abstract][Full Text] [Related]
3. [Antibiotic sensitivity of microorganisms, isolated from patients with opportunistic infections].
Tymchyk OV; Shapiro AV; Vasylenko OH
Mikrobiol Z; 2005; 67(5):64-8. PubMed ID: 16396113
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
Rossolini GM; Mantengoli E
Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
[TBL] [Abstract][Full Text] [Related]
5. Importance of antibiotic resistance and resistance mechanisms. Foreword.
Bonomo RA; Rossolini GM
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):549-50. PubMed ID: 18847392
[No Abstract] [Full Text] [Related]
6. Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps.
Amaral L; Martins M; Viveiros M
J Antimicrob Chemother; 2007 Jun; 59(6):1237-46. PubMed ID: 17218448
[TBL] [Abstract][Full Text] [Related]
7. Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.
Lomovskaya O; Bostian KA
Biochem Pharmacol; 2006 Mar; 71(7):910-8. PubMed ID: 16427026
[TBL] [Abstract][Full Text] [Related]
8. Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy.
Roveta S; Marchese A; Debbia EA
Chemotherapy; 2008; 54(1):43-9. PubMed ID: 18073470
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST).
Bouchillon SK; Iredell JR; Barkham T; Lee K; Dowzicky MJ
Int J Antimicrob Agents; 2009 Feb; 33(2):130-6. PubMed ID: 18995992
[TBL] [Abstract][Full Text] [Related]
10. [Efflux-mediated antibiotics resistance in bacteria].
Cattoir V
Pathol Biol (Paris); 2004 Dec; 52(10):607-16. PubMed ID: 15596311
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogs.
Pedersen K; Pedersen K; Jensen H; Finster K; Jensen VF; Heuer OE
J Antimicrob Chemother; 2007 Oct; 60(4):775-81. PubMed ID: 17644533
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for infection of the diabetic foot with multi-antibiotic resistant microorganisms.
Kandemir O; Akbay E; Sahin E; Milcan A; Gen R
J Infect; 2007 May; 54(5):439-45. PubMed ID: 17018235
[TBL] [Abstract][Full Text] [Related]
13. Bacterial efflux pump inhibitors from natural sources.
Stavri M; Piddock LJ; Gibbons S
J Antimicrob Chemother; 2007 Jun; 59(6):1247-60. PubMed ID: 17145734
[TBL] [Abstract][Full Text] [Related]
14. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
Hasdemir U
Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology of antibiotic resistance.
Gould IM
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S2-9. PubMed ID: 18757182
[TBL] [Abstract][Full Text] [Related]
16. Fighting infections due to multidrug-resistant Gram-positive pathogens.
Cornaglia G
Clin Microbiol Infect; 2009 Mar; 15(3):209-11. PubMed ID: 19335367
[TBL] [Abstract][Full Text] [Related]
17. Albomycin is an effective antibiotic, as exemplified with Yersinia enterocolitica and Streptococcus pneumoniae.
Pramanik A; Stroeher UH; Krejci J; Standish AJ; Bohn E; Paton JC; Autenrieth IB; Braun V
Int J Med Microbiol; 2007 Oct; 297(6):459-69. PubMed ID: 17459767
[TBL] [Abstract][Full Text] [Related]
18. In vitro antibacterial activity of aminosterols against multidrug-resistant bacteria from patients with cystic fibrosis.
Alhanout K; Brunel JM; Raoult D; Rolain JM
J Antimicrob Chemother; 2009 Oct; 64(4):810-4. PubMed ID: 19666647
[TBL] [Abstract][Full Text] [Related]
19. Clinical and economic burden of antimicrobial resistance.
Maragakis LL; Perencevich EN; Cosgrove SE
Expert Rev Anti Infect Ther; 2008 Oct; 6(5):751-63. PubMed ID: 18847410
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy.
Mahamoud A; Chevalier J; Alibert-Franco S; Kern WV; Pagès JM
J Antimicrob Chemother; 2007 Jun; 59(6):1223-9. PubMed ID: 17229832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
